Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1999;58:635-640; doi:10.1136/ard.58.10.635
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1999;58:635-640 ( October )

Extended report

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis Christian Witt, Adrian C Borges, Mathias John, Ingo Fietze, Gert Baumann, Andreas Krause

Department of Medicine, Charité University Hospital, Berlin, Germany

Correspondence to: Dr C Witt, Department of Medicine, Pneumology and Cardiology, Charité University Hospital, Schumannstrabeta e 20/21, D-10098 Berlin, Germany.

Accepted for publication 28 May 1999

OBJECTIVE---The clinical course of fibrosing alveolitis (FA) in patients with systemic sclerosis (SSc) may vary considerably from stable condition for years to continuous fatal progression. This prospective study aimed at identifying the prognostic value of bronchoalveolar lavage fluid (BALF) analysis in FASSc.
METHODS---Seventy three consecutive patients with SSc and clinical signs of pulmonary involvement were enrolled. Every patient underwent clinical examination, lung function tests, computed tomography (CT), gallium scan, echocardiography, and bronchoalveolar lavage (BAL). Forty nine patients, 26 with pathological and 23 with normal BALF findings were prospectively followed up for two years and re-evaluated annually.
RESULTS---At baseline, 51 subjects (70%) showed radiological signs of lung fibrosis and/or alveolitis by CT and diffusion capacity for carbon monoxide (DLco) was decreased in 47 patients (64%). Thirty five patients (48%) had pathological BALF findings. BALF differential counts included BALF granulocytosis in 18, BALF lymphocytosis in 12, and a mixed increase of both granulocytes and lymphocytes in five patients. On follow up, a progression of FA with a significant decrease of DLco was only observed in patients with BALF granulocytosis. In contrast, patients with BALF lymphocytosis or normal BALF cell count had stable lung funtion parameters during the study period. In none of our patients echocardiography showed evidence of pulmonary hypertension.
CONCLUSION---BALF granulocytosis predicts progression of FA with deterioration of lung function, which is most sensitively monitored by DLco. Immunosuppressive treatment is recommended in patients with granulocytic FASSc.


© 1999 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Savarino, E., Bazzica, M., Zentilin, P., Pohl, D., Parodi, A., Cittadini, G., Negrini, S., Indiveri, F., Tutuian, R., Savarino, V., Ghio, M. (2009). Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring. Am. J. Respir. Crit. Care Med. 179: 408-413 [Abstract] [Full Text]  
  • HARA, T., OGAWA, F., YANABA, K., IWATA, Y., MUROI, E., KOMURA, K., TAKENAKA, M., SHIMIZU, K., HASEGAWA, M., FUJIMOTO, M., SATO, S. (2009). Elevated Serum Concentrations of Polymorphonuclear Neutrophilic Leukocyte Elastase in Systemic Sclerosis: Association with Pulmonary Fibrosis. The Journal of Rheumatology 36: 99-105 [Abstract] [Full Text]  
  • Strange, C., Bolster, M. B., Roth, M. D., Silver, R. M., Theodore, A., Goldin, J., Clements, P., Chung, J., Elashoff, R. M., Suh, R., Smith, E. A., Furst, D. E., Tashkin, D. P., the Scleroderma Lung Study Research Group, (2008). Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease. Am. J. Respir. Crit. Care Med. 177: 91-98 [Abstract] [Full Text]  
  • Kowal-Bielecka, O, Kowal, K, Rojewska, J, Bodzenta-Lukaszyk, A, Siergiejko, Z, Sierakowska, M, Sierakowski, S (2005). Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations. Ann Rheum Dis 64: 1343-1346 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs